Get the Stockscreener App
8.27
1.19%
-0.10
Adma Biologics Inc stock is traded at $8.27, with a volume of 2.34M.
It is down -1.19% in the last 24 hours and down -4.94% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
See More
Previous Close:
$8.37
Open:
$8.4
24h Volume:
2.34M
Relative Volume:
0.52
Market Cap:
$1.92B
Revenue:
$509.86M
Net Income/Loss:
$165.35M
P/E Ratio:
12.20
EPS:
0.6779
Net Cash Flow:
$107.55M
1W Performance:
-5.05%
1M Performance:
-4.94%
6M Performance:
-50.57%
1Y Performance:
-52.22%
1-Day Range:
$8.165
$8.47
1-Week Range:
$8.165
$8.825
52-Week Range:
$7.2101
$20.46
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
8.27 | 1.92B | 509.86M | 165.35M | 107.55M | 0.6779 |
VRTX
Vertex Pharmaceuticals Inc
|
477.36 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
656.01 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
918.22 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
189.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.77 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-26 | Initiated | Canaccord Genuity | Buy |
| Mar-26-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
ADMA Shareholder Alert: ADMA Biologics, Inc. Securities Class Action LawsuitInvestors With Losses May Contact The Gross Law Firm - Supply Chain Digital
Lost Money on ADMA Biologics, Inc. (ADMA)? Urged to Join Class Action Before August 10, 2026Contact Levi & Korsinsky - ACCESS Newswire
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc.ADMA - PR Newswire
What Are the Allegations Against ADMA Biologics - Kavout | AI
Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
ADMA INVESTOR ALERT: ADMA Biologics, Inc. (ADMA) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit- HBSS - PR Newswire
ADMA|ADMA Biologics Inc|Price:8.375|Chg%:-0.005 - TradingKey
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ADMA - The National Law Review
ADMA BIOLOGICS CLASS ACTION REMINDER: Bragar Eagel & - GlobeNewswire
ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - lincolnjournal.com
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of ... - Caledonian Record
ADMA Biologics Shareholder Alert: ClaimsFiler Reminds - GlobeNewswire
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the ... - Caledonian Record
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Lost Money on ADMA BIOLOGICS, INC. (ADMA)? Join Class Action Suit Seeking RecoveryContact SueWallSt - PR Newswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors Urged to Contact Hagens Berman; Securities Fraud Class Action Filed - PR Newswire
ADMA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
ADMA Biologics Inc|Price:8.270 - TradingKey
How (ADMA) Movements Inform Risk Allocation Models - Stock Traders Daily
ADMA Alert: ADMA Biologics, Inc. (NASDAQ: ADMA) Investors - GlobeNewswire
ADMA Deadline: ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Conway Daily Sun
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - The Globe and Mail
ADMA Deadline Alert: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. (ADMA) Investors of Securities Class Action Deadline on August 10, 2026 - PR Newswire
ADMA BIOLOGICS, INC. INVESTORS WITH LOSSES HAVE UNTIL - GlobeNewswire
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
DEADLINE ALERT for VIA, Z, ADMA, and ERAS: The Law Offices - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of ADMA Biologics, Inc. Investors - GlobeNewswire
ADMA DEADLINE: The Gross Law Firm Reminds ADMA Biologics, Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire
Form 4 ADMA Biologics Inc For: 21 July By Investing.com - Investing.com South Africa
ADMA Lawsuit Notice: ADMA Biologics Channel Stuffing Allegations and 29% Stock Drop Trigger Securities Fraud Class Action - TradingView
ADMA Biologics Faces Securities Class Action Over Disclosure Failures - Intellectia AI
ADMA Shareholder Alert: ADMA BIOLOGICS, INC. Securities - GlobeNewswire
ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. ... - Caledonian Record
2026-07-19 | ADMA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:ADMA | Press Release - Stockhouse
ADMA Stock Downgraded By Cantor As ‘Channel Stuffing’ Claims Shake Investor Confidence - Stocktwits
ADMA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against PicS N.V. (PICS), BitGo Holdings, Inc. (BTGO), and ADMA Biologics, Inc. (ADMA) Announced by Holzer & Holzer, LLC - The Malone Telegram
Form 4 ADMA Biologics Inc For: 17 July By Investing.com - Investing.com Australia
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadl - GuruFocus
ADMA Biologics (NASDAQ: ADMA) grants CFO RSUs and $8.81 options - Stock Titan
ADMA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Deadline Alert: ADMA Biologics, Inc. (ADMA) Shareholders - GlobeNewswire
ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information About the Class Action Against ADMA Biologics, Inc. - The AI Journal
ADMA Tumbles On Slashed Outlook As Short-Seller Aftermath Meets Competitive Headwinds - Stocktwits
2026-07-17 | ADMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ADMA Biologics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:ADMA | Press Release - Stockhouse
ADMA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead ADMA Biologics Class Action Lawsuit - PR Newswire
ADMA DEADLINE: SueWallSt Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline - Sahm
2026-07-16 | ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline | NDAQ:ADMA | Press Release - Stockhouse
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adma Biologics Inc Stock (ADMA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Grossman Jerrold B | Director |
May 12 '26 |
Buy |
8.01 |
12,500 |
100,125 |
513,884 |
| Grossman Jerrold B | Director |
May 11 '26 |
Buy |
8.01 |
12,500 |
100,125 |
501,384 |
| Guiheen Lawrence P. | Director |
Mar 13 '26 |
Option Exercise |
3.66 |
30,000 |
109,800 |
135,520 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,133,777 |
| Grossman Adam S | President and CEO |
Mar 16 '26 |
Sale |
15.16 |
21,000 |
318,360 |
2,112,777 |
0.46%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):